The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb–mTORC1 signalling and leads to chronic heart failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|235|5|672-685

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.235, Iss.5, 2015-04, pp. : 672-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of chronic treprostinil treatment on experimental right heart hypertrophy and failure

By  

Cardiology in the Young, Vol. 27, Iss. 1, 2016-04 ,pp. : 90-100

Cambridge University Press

Access to resources Recommend Favorite

Harbingers of hypertrophy and heart failure

By Luft Friedrich  

Journal of Molecular Medicine, Vol. 82, Iss. 10, 2004-10 ,pp. : 635-637

Springer Publishing Company

Access to resources Recommend Favorite

mTORC1 et sirolimus

By Tartarin Pauline   Froment Pascal  

Médecine/sciences, Vol. 29, Iss. 2, 2013-02 ,pp. : 200-205

Edp Sciences

Access to resources Recommend Favorite

An Adenosine A1 Agonist 2-Chloro-N6 Cyclopentyladenosine Inhibits the Angiotensin II-Induced Cardiomyocyte Hypertrophy through the Calcineurin Pathway

By  

Cardiology, Vol. 129, Iss. 3, 2014-10 ,pp. : 153-162

Karger

Access to resources Recommend Favorite

The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II

By                  

International Journal of Molecular Medicine, Vol. 35, Iss. 5, 2015-01 ,pp. : 1159-1168

Spandidos Publications

Access to resources Recommend Favorite